KFSHRC Madinah Achieves Milestone With First Allogeneic Stem Cell Transplant For Leukemia Patients

King Faisal Specialist Hospital and Research Centre (KFSHRC) in Madinah has successfully completed its first allogeneic stem cell transplant for a patient with acute myeloid leukemia. This significant medical advancement allows patients with complex blood disorders in Madinah and nearby regions to access specialised treatment close to home.

The procedure involves replacing diseased bone marrow with healthy cells from a matched donor. It is used to treat conditions like leukemia, bone marrow failure, and immune disorders. The complexity of this treatment requires advanced expertise and infrastructure, making its success at KFSHRC Madinah a notable achievement.

KFSHRC's multidisciplinary teams collaborated from the outset to create a comprehensive plan. This included precise clinical protocols and integrated mechanisms between clinical, nursing, and laboratory departments. These efforts ensured the patient's stability and safe discharge after the transplant.

The hospital's capacity includes 400 beds, offering specialised services in fields such as adult and pediatric oncology, ophthalmology, and obstetrics and gynecology. Additionally, KFSHRC has received 14 training accreditations across various medical and nursing specialties.

KFSHRC has been ranked first in the Middle East and Africa and 15th globally among the top 250 academic medical centers for 2025. It is also recognised as the most valuable healthcare brand in Saudi Arabia and the Middle East by Brand Finance 2024.

Furthermore, Newsweek listed KFSHRC among the World’s Best Smart Hospitals for 2025. These accolades highlight its commitment to providing high-quality healthcare services.

The successful implementation of stem cell transplantation at KFSHRC Madinah enhances access to advanced specialty care for patients in the region. This development underscores the hospital's role in delivering cutting-edge medical treatments locally.

With inputs from SPA